Side by side.
Without fake winners.
Use comparisons to understand what is different — not to choose or change treatment without your clinician.
Flare medicines and urate-lowering medicines solve different problems. Suitability also depends on your health, other medicines and preferences.
What are you trying to understand?
Long-term urate lowering.
Long-term urate lowering.
Usually started low and adjusted against serum urate.
Used as a urate-lowering option, with choice influenced by clinical context.
It is not a painkiller. Existing ULT is not the same thing as acute flare treatment.
It is not a painkiller. Existing ULT is not the same thing as acute flare treatment.
Kidney function, dose titration, interactions and individual tolerance matter.
Cardiovascular history, other health factors and individual tolerance matter.
Reduce pain and inflammation.
Reduce gout inflammation.
Reduce inflammation.
No.
No.
No.
Kidney, stomach, bleeding and cardiovascular factors can matter.
Dose, kidney function, interactions and timing can matter.
Route, other conditions and repeated exposure can matter.
Convenient repeated trend tracking when the device and technique are reliable.
Clinical measurement used in diagnosis and treatment monitoring.
No. A home result does not diagnose gout.
A serum urate result is part of the clinical picture; a number alone does not prove gout.
Convenience and frequency.
Clinical standardisation and integration with medical care.
“How are these different?” beats “Which one wins?”
GoutSense comparisons are descriptive. We will show purpose, evidence, limitations and practical differences without ranking treatment choices for an individual.